ATHA

Athira Pharma, Inc. ATHA

ATHA
Athira Pharma, Inc. LPTX
Leap Therapeutics, Inc. CTXR
Citius Pharmaceuticals, Inc. ICU
SeaStar Medical Holding Corporation APLM
Apollomics, Inc. MBRX
Moleculin Biotech, Inc. CRIS
Curis, Inc. FBLG
FibroBiologics, Inc. Common Stock LNAI
Lunai Bioworks Inc. ADTX
Aditxt, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode ATHA LPTX CTXR ICU APLM MBRX CRIS FBLG LNAI ADTX
6M 131.09 % 314.45 % -33.28 % -42.79 % 196.38 % -47.01 % -51.61 % -67.25 % -56.75 % -99.38 %
YTD 31.09 % -63.66 % -79.37 % -87.59 % 66.57 % -91.19 % -75.24 % -88.15 % -56.75 % -99.98 %
1Y 33.77 % -60.74 % -75.81 % -88.42 % 71.50 % -91.19 % -66.56 % -89.79 % -56.75 % -99.98 %
3Y -75.81 % -72.98 % -96.02 % -99.77 % -98.26 % -99.06 % -88.83 % -99.19 % -56.75 % -100.00 %
5Y -97.74 % -94.71 % -97.01 % -99.91 % -98.18 % -99.81 % -99.33 % -99.19 % -56.75 % -100.00 %
10Y -95.79 % -98.51 % -99.88 % -99.91 % -98.18 % -99.98 % -99.63 % -99.19 % -56.75 % -100.00 %
Depuis le début -95.79 % -98.51 % -99.79 % -99.91 % -98.18 % -99.98 % -99.96 % -99.19 % -56.75 % -100.00 %

Dividende